Barbexaclone

From Wikipedia, the free encyclopedia
Jump to: navigation, search
Barbexaclone
Barbexaclon Structural Formula V1.svg
Combination of
Phenobarbital Barbiturate
Propylhexedrine Stimulant (sympathomimetic)
Clinical data
AHFS/Drugs.com International Drug Names
Identifiers
4388-82-3 YesY
N03AA04
PubChem CID 71196
DrugBank DB09001 N
ChemSpider 64332 YesY
UNII 291GX1YB65 YesY
 N (what is this?)  (verify)

Barbexaclone (Maliasin) is a salt compound of phenobarbital and levopropylhexedrine. It was introduced in 1983. It has been reported to be as effective as phenobarbital but better tolerated; however, as of 2004, these "promising results" had not yet been confirmed nor denied in controlled trials. 100 mg of barbexaclone is equivalent to 60 mg of phenobarbital.

References[edit]

  • The Treatment of Epilepsy 2nd Ed by S. D. Shorvon (Editor), David R. Fish (Editor), Emilio Perucca (Editor), W. Edwin Dodson (Editor). Published by Blackwell 2004. p. 472. ISBN 0-632-06046-8